Butyrate, for example, induces apoptosis in CRC cells by inhibiting histone deacetylases (HDACs), whereas an imbalance in secondary bile acids can activate inflammatory pathways like NF-κB, driving tumor proliferation and immune evasion (Qu et al., 2023). Here, NFKB1 is linked to neoplasm.